A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use
- 18 October 2000
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 245 (1-2) , 15-29
- https://doi.org/10.1016/s0022-1759(00)00269-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in VivoThe Journal of Experimental Medicine, 2000
- Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cellsJournal of Clinical Investigation, 1999
- GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trialThe Prostate, 1999
- Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditionsEuropean Journal of Immunology, 1997
- Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.The Journal of Experimental Medicine, 1995
- Activation of human dendritic cells through CD40 cross-linking.The Journal of Experimental Medicine, 1994
- Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.Journal of Clinical Investigation, 1994
- Proliferating dendritic cell progenitors in human blood.The Journal of Experimental Medicine, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature, 1992